ACX-362E a Promising Potential Treatment for C difficile, First-in-Human Phase 1 Trial Demonstrates
October 2nd 2019Investigators observed no moderate, severe, cumulative, or dose-limiting adverse events leading to discontinuation, and ACX-362E was generally well-tolerated at all dose levels.
Read More
Early Detection and Quick Infection Prevention Support Key to Tackling Candida Auris
October 2nd 2019When it came to infection prevention measures, 5 of the 9 Orange County facilities with C auris displayed hand hygiene adherence < 50%, 3 had limited access to alcohol-based hand rubs, and < 60% of assessed high-touch surfaces were clean.
Read More
Dr. Joseph Fair: From the Lab to the Field, 'Virus Hunter' Battles Ebola in the DRC
September 25th 2019In part 1 of our Q&A with Fair, we talk about his background, education, and experience, and also how the outbreak response to the current Ebola outbreak in the DRC differs from traditional disaster response.
Read More
Leprosy Outbreak in United States Only a 'Matter of Time,' One Physician Argues
September 12th 2019Even though leprosy is not widespread in the United States, the current landscape in some cities, such as Los Angeles, is creating the perfect environment for so-called “ancient” diseases to flourish.
Read More
EEE Threat Level Raised in Massachusetts Following First Fatality
September 2nd 2019The total number of communities at critical risk of the mosquito-borne Eastern equine encephalitis stands at 28 statewide. Thirty-seven other towns are considered at high risk for EEE, while 126 are at moderate risk.
Read More